Virtual Taster Lecture Series - Engineering the future of cancer therapy

This webinar will be an insightful journey into the cutting-edge technologies transforming cancer treatment. This presentation will explore the critical role of lentiviral vectors in genetically engineering CAR-T cells, the groundbreaking therapy that empowers the immune system to target and eliminate cancer. We will discuss the challenges of prolonged manufacturing times and high production costs, highlighting innovative solutions to make these life-saving therapies more efficient, accessible, and affordable. Discover how advancements in manufacturing are shaping the future of cancer treatment and inspiring the next generation of life-saving therapies.

The Engineering Virtual Taster Lecture Series is an annual set of online presentations from researchers and academics at UCL Biochemical Engineering. It gives our academics and researchers a chance to present their work, and explain what biochemical engineering is and the global challenges we're helping to overcome. We're looking forward to welcoming you and taking your questions.

UCL uses a third party (Zoom) to administer our webinar/virtual open days and manage your personal information on our behalf. If you are happy for us to process your data solely for this purpose, please continue by entering your details in the registration form.

Our Prospective Student Privacy notice is available here